Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 37% ± 13% | |
peripheral blood | 18 studies | 36% ± 11% | |
brain | 18 studies | 35% ± 19% | |
intestine | 11 studies | 23% ± 7% | |
eye | 11 studies | 40% ± 15% | |
kidney | 10 studies | 28% ± 6% | |
heart | 5 studies | 24% ± 3% | |
lymph node | 5 studies | 29% ± 4% | |
liver | 5 studies | 36% ± 9% | |
pancreas | 4 studies | 50% ± 19% | |
bone marrow | 4 studies | 32% ± 10% | |
uterus | 4 studies | 42% ± 14% | |
breast | 4 studies | 31% ± 6% | |
prostate | 4 studies | 32% ± 10% | |
adipose | 4 studies | 29% ± 4% | |
placenta | 3 studies | 41% ± 11% | |
esophagus | 3 studies | 32% ± 17% | |
skin | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 6133.05 | 359 / 359 | 100% | 52.65 | 286 / 286 |
brain | 100% | 6269.19 | 2640 / 2642 | 100% | 67.95 | 705 / 705 |
breast | 100% | 6152.60 | 459 / 459 | 100% | 71.55 | 1117 / 1118 |
lung | 100% | 6483.48 | 577 / 578 | 100% | 66.75 | 1155 / 1155 |
prostate | 100% | 6301.54 | 245 / 245 | 100% | 71.50 | 501 / 502 |
uterus | 100% | 5977.06 | 170 / 170 | 100% | 51.79 | 457 / 459 |
thymus | 100% | 6276.57 | 653 / 653 | 100% | 67.76 | 602 / 605 |
esophagus | 100% | 8168.10 | 1445 / 1445 | 99% | 54.17 | 182 / 183 |
bladder | 100% | 8138.62 | 21 / 21 | 99% | 61.05 | 501 / 504 |
kidney | 100% | 5933.19 | 89 / 89 | 99% | 54.49 | 895 / 901 |
pancreas | 100% | 3882.93 | 327 / 328 | 99% | 58.01 | 177 / 178 |
adrenal gland | 100% | 13888.47 | 258 / 258 | 99% | 62.34 | 228 / 230 |
intestine | 100% | 7439.24 | 966 / 966 | 99% | 58.95 | 522 / 527 |
ovary | 100% | 5309.58 | 180 / 180 | 99% | 31.56 | 425 / 430 |
liver | 100% | 3104.20 | 225 / 226 | 99% | 37.26 | 402 / 406 |
skin | 100% | 6267.20 | 1809 / 1809 | 96% | 80.10 | 452 / 472 |
adipose | 100% | 6058.77 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 8568.62 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 36.29 | 29 / 29 |
muscle | 100% | 7612.85 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5499.59 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 44.85 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 24.00 | 1 / 1 |
heart | 96% | 6687.96 | 827 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 4737.01 | 861 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 65% | 22.19 | 52 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045087 | Biological process | innate immune response |
GO_0006915 | Biological process | apoptotic process |
GO_0006914 | Biological process | autophagy |
GO_0034144 | Biological process | negative regulation of toll-like receptor 4 signaling pathway |
GO_0039532 | Biological process | negative regulation of cytoplasmic pattern recognition receptor signaling pathway |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_1905161 | Biological process | protein localization to phagocytic vesicle |
GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0000407 | Cellular component | phagophore assembly site |
GO_0005776 | Cellular component | autophagosome |
GO_0005739 | Cellular component | mitochondrion |
GO_0019900 | Molecular function | kinase binding |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | TAX1BP1 |
Protein name | Tax1-binding protein 1 (TRAF6-binding protein) Tax1 binding protein 1 Alternative protein TAX1BP1 |
Synonyms | T6BP PRO0105 |
Description | FUNCTION: Ubiquitin-binding adapter that participates in inflammatory, antiviral and innate immune processes as well as selective autophagy regulation . Plays a key role in the negative regulation of NF-kappa-B and IRF3 signalings by acting as an adapter for the ubiquitin-editing enzyme A20/TNFAIP3 to bind and inactivate its substrates . Disrupts the interactions between the E3 ubiquitin ligase TRAF3 and TBK1/IKBKE to attenuate 'Lys63'-linked polyubiquitination of TBK1 and thereby IFN-beta production . Recruits also A20/TNFAIP3 to ubiquitinated signaling proteins TRAF6 and RIPK1, leading to their deubiquitination and disruption of IL-1 and TNF-induced NF-kappa-B signaling pathways . Inhibits virus-induced apoptosis by inducing the 'Lys-48'-linked polyubiquitination and degradation of MAVS via recruitment of the E3 ligase ITCH, thereby attenuating MAVS-mediated apoptosis signaling . As a macroautophagy/autophagy receptor, facilitates the xenophagic clearance of pathogenic bacteria such as Salmonella typhimurium and Mycobacterium tuberculosis . Upon NBR1 recruitment to the SQSTM1-ubiquitin condensates, acts as the major recruiter of RB1CC1 to these ubiquitin condensates to promote their autophagic degradation . Mediates the autophagic degradation of other substrates including TICAM1 . . |
Accessions | ENST00000396319.7 [Q86VP1-1] Q86VP1 ENST00000433216.6 [Q86VP1-4] ENST00000265393.10 [Q86VP1-2] ENST00000409980.5 L8E7U3 V9GZ06 ENST00000418691.5 C9JBZ7 B8ZZD4 ENST00000457186.2 C9J7J4 ENST00000543117.5 [Q86VP1-2] ENST00000416801.6 F8WBU9 ENST00000488564.2 H7C3L5 ENST00000422800.5 |